Skip to content Skip to footer

Ascentage Pharma Announces Another Milestone Payment from Its Licensee UNITY Biotechnology, Rapidly Advancing the Clinical Development of Senolytic Drug Candidate UBX1325

Langgan

Surat Berita

订阅我们的月讯

Subscribe to our

Newsletter